231 related articles for article (PubMed ID: 21326872)
1. PKCδ sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage.
Marengo B; De Ciucis C; Ricciarelli R; Passalacqua M; Nitti M; Zingg JM; Marinari UM; Pronzato MA; Domenicotti C
PLoS One; 2011 Feb; 6(2):e14661. PubMed ID: 21326872
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma.
Marengo B; De Ciucis C; Verzola D; Pistoia V; Raffaghello L; Patriarca S; Balbis E; Traverso N; Cottalasso D; Pronzato MA; Marinari UM; Domenicotti C
Free Radic Biol Med; 2008 Feb; 44(3):474-82. PubMed ID: 17991446
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E, γ-tocotrienol, Protects Against Buthionine Sulfoximine-Induced Cell Death by Scavenging Free Radicals in SH-SY5Y Neuroblastoma Cells.
Tan JK; Then SM; Mazlan M; Jamal R; Ngah WZ
Nutr Cancer; 2016; 68(3):507-17. PubMed ID: 27008382
[TBL] [Abstract][Full Text] [Related]
5. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.
Anderson CP; Tsai JM; Meek WE; Liu RM; Tang Y; Forman HJ; Reynolds CP
Exp Cell Res; 1999 Jan; 246(1):183-92. PubMed ID: 9882527
[TBL] [Abstract][Full Text] [Related]
6. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
7. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
Cuperus R; van Kuilenburg AB; Leen R; Bras J; Caron HN; Tytgat GA
Free Radic Biol Med; 2011 Sep; 51(6):1213-20. PubMed ID: 21741474
[TBL] [Abstract][Full Text] [Related]
8. Role of PKC-delta activity in glutathione-depleted neuroblastoma cells.
Domenicotti C; Marengo B; Verzola D; Garibotto G; Traverso N; Patriarca S; Maloberti G; Cottalasso D; Poli G; Passalacqua M; Melloni E; Pronzato MA; Marinari UM
Free Radic Biol Med; 2003 Sep; 35(5):504-16. PubMed ID: 12927600
[TBL] [Abstract][Full Text] [Related]
9. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis.
Stokes AH; Lewis DY; Lash LH; Jerome WG; Grant KW; Aschner M; Vrana KE
Brain Res; 2000 Mar; 858(1):1-8. PubMed ID: 10700589
[TBL] [Abstract][Full Text] [Related]
10. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.
Anderson CP; Tsai J; Chan W; Park CK; Tian L; Lui RM; Forman HJ; Reynolds CP
Eur J Cancer; 1997 Oct; 33(12):2016-9. PubMed ID: 9516845
[TBL] [Abstract][Full Text] [Related]
11. Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1.
Furfaro AL; Macay JR; Marengo B; Nitti M; Parodi A; Fenoglio D; Marinari UM; Pronzato MA; Domenicotti C; Traverso N
Free Radic Biol Med; 2012 Jan; 52(2):488-96. PubMed ID: 22142473
[TBL] [Abstract][Full Text] [Related]
12. GSH loss per se does not affect neuroblastoma survival and is not genotoxic.
Marengo B; Balbis E; Patriarca S; De Ciucis C; Furfaro A; Nitti M; Marinari UM; Pronzato MA; Traverso N; Domenicotti C
Int J Oncol; 2008 Jan; 32(1):121-7. PubMed ID: 18097550
[TBL] [Abstract][Full Text] [Related]
13. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.
Colla R; Izzotti A; De Ciucis C; Fenoglio D; Ravera S; Speciale A; Ricciarelli R; Furfaro AL; Pulliero A; Passalacqua M; Traverso N; Pronzato MA; Domenicotti C; Marengo B
Oncotarget; 2016 Oct; 7(43):70715-70737. PubMed ID: 27683112
[TBL] [Abstract][Full Text] [Related]
15. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
[TBL] [Abstract][Full Text] [Related]
16. Curcumin sensitizes lung adenocarcinoma cells to apoptosis via intracellular redox status mediated pathway.
Kaushik G; Kaushik T; Yadav SK; Sharma SK; Ranawat P; Khanduja KL; Pathak CM
Indian J Exp Biol; 2012 Dec; 50(12):853-61. PubMed ID: 23986968
[TBL] [Abstract][Full Text] [Related]
17. Buthionine sulfoximine and 1,25-dihydroxyvitamin D induce apoptosis in breast cancer cells via induction of reactive oxygen species.
Bohl LP; Liaudat AC; Picotto G; Marchionatti AM; Narvaez CJ; Welsh J; Rodriguez VA; Tolosa de Talamoni NG
Cancer Invest; 2012 Oct; 30(8):560-70. PubMed ID: 22931489
[TBL] [Abstract][Full Text] [Related]
18. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.
Zhu Z; Du S; Du Y; Ren J; Ying G; Yan Z
J Neurochem; 2018 Jan; 144(1):93-104. PubMed ID: 29105080
[TBL] [Abstract][Full Text] [Related]
19. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.
Anderson CP; Seeger RC; Satake N; Monforte-Munoz HL; Keshelava N; Bailey HH; Reynolds CP
J Pediatr Hematol Oncol; 2001 Nov; 23(8):500-5. PubMed ID: 11878777
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
